Trade

with

OraSure Technologies Inc
(NASDAQ: OSUR)
AdChoices
8.34
-0.27
-3.08%
After Hours :
8.34
+0.00
+0.06%

Open

8.64

Previous Close

8.60

Volume (Avg)

1.00M (542.83k)

Day's Range

8.31-8.74

52Wk Range

5.34-9.58

Market Cap.

466.65M

Dividend Rate ( Yield )

-

Beta

1.71

Shares Outstanding

55.99M

P/E Ratio (EPS)

384.62 (0.02)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 98.94M

    • Net Income

    • -11.19M

    • Market Cap.

    • 466.65M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 1.18

    • PEG (Price/Earnings Growth) Ratio

    • 20.85

    • Beta

    • 1.71

    • Forward P/E

    • 416.67

    • Price/Sales

    • 4.49

    • Price/Book Value

    • 2.91

    • Price/Cash flow

    • 64.10

      • EBITDA

      • -5.41M

      • Return on Capital %

      • 0.69

      • Return on Equity %

      • 0.77

      • Return on Assets %

      • 0.69

      • Book Value/Share

      • 2.86

      • Shares Outstanding

      • 55.99M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 10.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 0.02

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 8.50

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 6.83

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 59.98

            • 52.83

            • Pre-Tax Margin

            • 1.03

            • 15.96

            • Net Profit Margin

            • 1.18

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 62.00

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -11.70

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -10.80

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 7.87

              • 1.97

              • Quick Ratio

              • 6.42

              • 1.16

              • Interest Coverage

              • -

              • 10.47

              • Leverage Ratio

              • 1.12

              • 2.38

              • Book Value/Share

              • 2.86

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 384.62

                • 35.09

                • P/E Ratio 5-Year High

                • 640.46

                • 279.76

                • P/E Ratio 5-Year Low

                • 145.37

                • 148.87

                • Price/Sales Ratio

                • 4.50

                • 3.22

                • Price/Book Value

                • 2.91

                • 4.03

                • Price/Cash Flow Ratio

                • 64.10

                • 16.69

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 0.77

                        (-7.50)

                      • 17.93

                        (21.42)

                      • Return on Assets %

                        (5-Year Average)

                      • 0.69

                        (-6.30)

                      • 7.35

                        (9.50)

                      • Return on Capital %

                        (5-Year Average)

                      • 0.77

                        (-7.30)

                      • 10.24

                        (13.59)

                      • Income/Employee

                      • 4.16k

                      • 25.65k

                      • Inventory Turnover

                      • 3.22

                      • 2.66

                      • Asset Turnover

                      • 0.58

                      • 0.59

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -12.16M
                      Operating Margin
                      -12.29
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      64.10
                      Ownership

                      Institutional Ownership

                      79.31%

                      Top 10 Institutions

                      45.93%

                      Mutual Fund Ownership

                      39.41%

                      Float

                      71.40%

                      5% / Insider Ownership

                      7.46%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Wells Fargo Advantage Small Cap Value Fd

                      •  

                        4,900,600

                      • -2.17

                      • 8.75

                      • PrimeCap Odyssey Aggressive Growth Fund

                      •  

                        1,523,900

                      • -5.21

                      • 2.72

                      • BlackRock Master Value Opportunities LLC

                      •  

                        1,511,103

                      • 5.88

                      • 2.70

                      • Eaton Vance Worldwide Health Sciences Fu

                      •  

                        1,145,000

                      • 0.00

                      • 2.05

                      • iShares Russell 2000 (AU)

                      •  

                        879,945

                      • 3.56

                      • 1.87

                      • Vanguard Total Stock Mkt Idx

                      •  

                        857,713

                      • 0.00

                      • 1.53

                      • TIAA-CREF Small-Cap Equity

                      •  

                        750,245

                      • 8.41

                      • 1.34

                      • Worldwide Healthcare

                      •  

                        710,000

                      • 0.00

                      • 1.27

                      • Legg Mason Royce US Small Cap Opp

                      •  

                        632,821

                      • 30.48

                      • 1.13

                      • Vanguard Extended Market Index Fund

                      •  

                        623,088

                      • 0.46

                      • 1.11

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Wells Capital Management Inc.

                      •  

                        6,375,689

                      • -13.88%

                      • 11.39

                      • Orbimed Advisors, LLC

                      •  

                        5,372,000

                      • 0.00%

                      • 9.60

                      • BlackRock Advisors LLC

                      •  

                        2,079,534

                      • -18.31%

                      • 3.71

                      • PRIMECAP Management Company

                      •  

                        2,025,400

                      • -6.39%

                      • 3.62

                      • Cortina Asset Management LLC

                      •  

                        2,003,398

                      • +24.38%

                      • 3.58

                      • Columbus Circle Investors

                      •  

                        1,873,510

                      • +1.68%

                      • 3.35

                      • BlackRock Fund Advisors

                      •  

                        1,845,861

                      • -0.86%

                      • 3.30

                      • Vanguard Group, Inc.

                      •  

                        1,743,073

                      • +0.29%

                      • 3.11

                      • Thomson Horstmann & Bryant, Inc.

                      •  

                        1,326,083

                      • +9.55%

                      • 2.37

                      • Tocqueville Asset Management L.P.

                      •  

                        1,062,863

                      • +23.26%

                      • 1.90

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Instruments & Supplies

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      OraSure Technologies Inc was formed in May 2000 under Delaware law solely for the purposes of combining two companies, STC Technologies, Inc. and Epitope, Inc. and changing the state of incorporation of Epitope from Oregon to Delawar...moree. The Company is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. Its diagnostic products include tests that are performed at the point of care and tests that are processed in a laboratory. These produc...morets are sold in the United States and internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities. One of its diagnostic products, the OraQuick In-Home HIV Test got approved by the U.S. FDA for sale in the over-the-counter or consumer retail markets in the United States. Its in vitro diagnostic testing is the process of analyzing oral fluid, blood, urine and other bodily fluids or tissue for the presence of specific substances or markers. Through its subsidiary, DNAG, the Company manufacture and sell kits that are used to collect, stabilize, and store samples of genetic material for molecular testing in the consumer genetics, clinical genetic testing, academic research, pharmacogenomics, personalized medicine, and animal genetics markets. The Company owns rights to trademarks and service marks that are necessary to conduct its business as currently operated. In the United States, it owns the OraSure, Intercept, OraQuick, OraQuick ADVANCE, Histofreezer, OraSure QuickFlu, Q.E.D., Oragene, ORAcollect, OMNIgene, Performagene, PrepIT, HEMAgene, and AUTO-LYTE. The competitors include medical diagnostic companies and specialized biotechnology firms, as well as pharmaceutical companies with biotechnology divisions The Company is subject to other federal and state laws targeting fraud and abuse in the healthcare industry, including false claims laws, marketing conduct laws and laws constraining the sales, marketing and other promotional activities of manufacturers of medical devices by limiting the kinds of financial arrangements, including sales programs, with physicians, hospitals, laboratories and other potential purchasers of medical devices.lessless

                      Key People

                      Douglas A. Michels

                      CEO/Director/President

                      Douglas G. Watson

                      Chairman of the Board/Director

                      Ronald H. Spair

                      CFO/COO/Director

                      Mr. Anthony (Tony) Zezzo, II,

                      Executive VP, Divisional

                      Mr. Ronny B. Lancaster

                      Director

                      • OraSure Technologies Inc

                      • 220 East First Street

                      • Bethlehem, PA 18015

                      • USA.Map

                      • Phone: +1 610 882-1820

                      • Fax: +1 610 882-1830

                      • orasure.com

                      Incorporated

                      2000

                      Employees

                      293

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: